Finance

Lists
EFX:NYSE
Equifax Inc
$174.11
+0.86%
(+1.49) 1D
$174.11
0.00% (0.00)
After hours
Closed: Aug 3, 4:00:10 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EFX...
Open
$175.21
High
$179.72
Low
$173.99
Mkt. cap
20.46B
Avg. vol.
1.94M
Volume
86.00
Dividend
1.29%
Quarterly dividend
$0.56
Ex-dividend date
May 22, 2026
P/E ratio
30.59
52-wk high
$271.84
52-wk low
$150.74
EPS
$5.69
Beta
1.32
Shares outstanding
117.48M
No. of employees
15K
Open
$175.21
High
$179.72
Low
$173.99
Mkt. cap
20.46B
Avg. vol.
1.94M
Volume
86.00
Dividend
1.29%
Quarterly dividend
$0.56
Ex-dividend date
May 22, 2026
P/E ratio
30.59
52-wk high
$271.84
52-wk low
$150.74
EPS
$5.69
Beta
1.32
Shares outstanding
117.48M
No. of employees
15K
News stories
From sources across the web
Profile
Equifax Inc. is an American multinational consumer credit reporting agency headquartered in Atlanta, Georgia, and is one of the three largest consumer credit reporting agencies, along with Experian and TransUnion. Equifax collects and aggregates information on more than 800 million individual consumers and more than 88 million businesses worldwide. In addition to credit and demographic data and services to business, Equifax sells credit monitoring and fraud prevention services directly to consumers. Equifax operates or has investments in 24 countries in the Americas, Europe, and Asia Pacific. With more than 14,000 employees worldwide, Equifax has nearly US$5 billion in annual revenue and is traded on the New York Stock Exchange under the symbol EFX. Wikipedia
About Equifax Inc
CEOMark Begor
Employees15K
Founded1899
HeadquartersAtlanta, Georgia, United States
SectorService
Analyst ratings
Based on 20 analysts giving stock ratings to EFX in the past 3 months
Strong buy
Buy
15
Hold
5
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for EFX in the last 3 months.
Highest
Current $174.11
$245.00 (+40.72%)
Average
$209.89 (+20.55%)
Lowest
$179.00 (+2.81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Oppenheimer
Buy
Reiterated
$206.00
+18.3%
07/24/2026
Andrew Steinerman
J.P. Morgan
Buy
Maintained
$210.00
+20.6%
07/23/2026
John Eade
Argus Research
Hold
Maintained
-
-
07/21/2026
Jeffrey Silber
BMO Capital
Hold
Maintained
$179.00
+2.8%
07/22/2026
Faiza Alwy
Deutsche Bank
Buy
Reiterated
$208.00
+19.5%
07/22/2026
Shlomo Rosenbaum
Stifel Nicolaus
Buy
Maintained
$235.00
+35%
07/22/2026
Jason Haas CFA
Wells Fargo
Buy
Maintained
$212.00
+21.8%
07/22/2026
Ashish Sabadra
RBC Capital
Buy
Maintained
$194.00
+11.4%
07/21/2026
Toni Kaplan
Morgan Stanley
Buy
Maintained
$225.00
+29.2%
07/22/2026
Kyle Peterson
Needham
Buy
Reiterated
$245.00
+40.7%
07/22/2026
Jeffrey Meuler
Robert W. Baird
Buy
Maintained
$232.00
+33.2%
07/22/2026
Owen Lau
Clear Street
Hold
Reiterated
$190.00
+9.1%
07/22/2026
Curtis Nagle
Bank of America Securities
Buy
Reiterated
$210.00
+20.6%
07/22/2026
Manav Patnaik
Barclays
Hold
Maintained
$200.00
+14.9%
07/22/2026
Andrew Nicholas
William Blair
Buy
Maintained
-
-
07/21/2026
Arthur Truslove
Citi
Buy
Maintained
$220.00
+26.4%
07/22/2026
George Tong
Goldman Sachs
Hold
Maintained
$182.00
+4.5%
07/21/2026
Ryan Griffin CFA
BMO Capital
Hold
Maintained
$179.00
+2.8%
07/13/2026
Unknown Analyst
Jefferies
Buy
Maintained
$200.00
+14.9%
07/08/2026
Kevin Mcveigh
UBS
Buy
Reiterated
$220.00
+26.4%
07/02/2026
Sean Kennedy
Mizuho Securities
Buy
Maintained
$210.00
+20.6%
07/02/2026
Unknown Analyst
Mizuho Securities
Buy
Initiated
$222.00
+27.5%
04/16/2026
Rayna Kumar
Oppenheimer
Buy
Reiterated
$248.00
+42.4%
04/07/2026
Alexander Hess
J.P. Morgan
Buy
Maintained
$230.00
+32.1%
02/04/2026
Last report
Jul 21, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$2.25 / $2.20
+2.28%beat
Revenue / Est. (USD)
1.70B / 1.70B
+0.20%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.54B
1.55B
1.65B
1.70B
Cost of goods sold
663.20M
661.20M
767.10M
773.70M
Cost of revenue
663.20M
661.20M
767.10M
773.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
390.20M
424.40M
411.00M
442.50M
Operating expense
573.50M
608.60M
594.10M
632.20M
Total operating expenses
1.24B
1.27B
1.36B
1.41B
Operating income
308.20M
280.80M
287.70M
294.20M
Other non operating income
3.90M
8.30M
3.60M
3.10M
EBT including unusual items
215.30M
232.90M
235.80M
256.90M
EBT excluding unusual items
259.90M
235.00M
235.60M
237.50M
Income tax expense
53.80M
56.50M
62.50M
71.80M
Effective tax rate
24.99%
24.26%
26.51%
27.95%
Other operating expenses
-
-
-
-
Net income
160.20M
175.80M
171.50M
183.90M
Net profit margin
10.37%
11.34%
10.40%
10.82%
Earnings per share
2.04
2.09
1.86
2.25
Interest and investment income
-
-
-
-
Interest expense
-52.20M
-54.10M
-55.70M
-59.80M
Net interest expenses
-52.20M
-54.10M
-55.70M
-59.80M
Depreciation and amortization charges
183.30M
184.20M
183.10M
189.70M
EBITDA
493.30M
466.90M
472.50M
485.60M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps